Arwana Citramulia Tbk (ARNA)
Jakarta Exchange · Indonesia · prices in IDR · close of 22 Oct 2026
Key indicators
| Last close | IDR 505.00 |
|---|---|
| 52-week range | 392.00 – 560.00 |
| Return, 1 month / 3 months | +1.4% / +5.6% |
| Return, 1 year / 3 years | +5.9% / −8.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 18.1% |
| Worst drawdown (1 year) | -20.6% |
| Average daily value traded | 2,198.91M IDR |
| Dividend yield | 8.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Arwana Citramulia Tbk is an Indonesian manufacturer of ceramic tiles, making floor and wall tiles for homes, commercial buildings and construction projects. The company produces its tiles at plants in Indonesia and offers them under its own brand names, serving customers through distributors, retailers and building-material outlets across the country and in export markets. Its headquarters and manufacturing operations are based in Indonesia.
On this site Arwana Citramulia Tbk appears as a stock on the Jakarta Exchange (Indonesia), code ARNA, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Arwana Citramulia Tbk (ARNA) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 505.00 on 22 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 35 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.9% and over the last three months it rose 5.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 4.7% | ||
| From 52-week high | -9.8% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.6% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 4.4% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.6% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 2,198.91M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | +1.4% |
| 3 months | +5.6% |
| 6 months | +0.0% |
| 1 year | +5.9% |
| 3 years | −8.6% |
| 5 years | −15.0% |
Signals
| 50-day / 200-day average | 507.26 / 482.22 |
|---|---|
| Golden / death cross (60 days) | Golden, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 20.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Apr 2026 | IDR 45.0000 |
| 17 Apr 2025 | IDR 43.0000 |
| 17 Apr 2024 | IDR 43.0000 |
| 20 Mar 2023 | IDR 55.0000 |
| 17 Mar 2022 | IDR 45.0000 |
| 18 Mar 2021 | IDR 30.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.